
Small Caps
314 FOLLOWERS
Small Caps is Australia's #1 site for market news & information on ASX-listed small-cap companies. The podcast keeps investors informed by showcasing interviews with directors of ASX-listed small-cap companies and financial market analysts.
Small Caps
6d ago
Ideon Technologies vice president of customer experience Kim Lawrence joins Small Caps to discuss its groundbreaking muon tomography technology.
The Canadian based company uses cosmic rays to detect ore bodies deep beneath the Earth's surface without disturbing the environment.
Ideon's non-invasive approach offers a wealth of benefits for the mining industry by reducing environmental impact by eliminating the need for extensive drilling, improved exploration efficiency providing a more comprehensive understanding of the subsurface, enabling miners to pinpoint ore bodies with greater precision ..read more
Small Caps
1w ago
Tambourah Metals (ASX: TMB) chairperson Rita Brooks joins Small Caps to discuss the company's highly active gold and lithium exploration campaigns in Western Australia.
Within the last few days Tambourah has announced drilling success at its Tambourah King gold target and identified significant lithium exploration upside at the Russian Jack project.
Tambourah's first assay results from an RC drill program at the Tambourah gold and lithium project in the Pilbara confirmed the historic goldfield has the potential to encompass high-grade gold mineralisation.
Notable results included very high-gra ..read more
Small Caps
1w ago
Galan Lithium (ASX: GLN) managing director Juan Pablo Vargas de la Vega joins Small Caps to discuss to recent signing of significant offtake agreement with global mining giant Glencore for its Hombre Muerto West (HMW) project in Argentina.
The binding offtake deal is for lithium chloride and/or lithium carbonate from Phase 1 production at HMW.
Notably, Glencore has also offered to potential provide Galan with a $107 million to $151 million in support of a financing prepayment facility for the project.
Galan considers the Glencore agreement as a validation of the world class quality of the HMW ..read more
Small Caps
1w ago
Frontier Digital Ventures (ASX: FDV) founder and chief executive officer Shaun Di Gregorio joins Small Caps to discuss the online classified marketplace specialist’s continuing run of revenue momentum.
The company recently reported that for the fifth consecutive quarter each of its geographic regions achieved positive operating cashflows.
Notably, the FDV Group also achieved its third consecutive quarter of positive operating cashflows, which included its holding company costs.
The growing revenue momentum was supported by new product initiatives and transaction revenues.
The recent launch of ..read more
Small Caps
1w ago
Peppermint Innovation (ASX: PIL) managing director and chief executive officer Chris Kain joins Small Caps to discuss the company's recent of run of success as it continues to expand its innovative fintech business in the Philippines and globally.
Amongst the numerous milestones achieved recently is the company’s signing of an exclusive five-year agreement with Visa to significantly expand its digital financial offering.
The company will initially focus on its key markets in the Philippines, Singapore and Australia before taking its business model around the world.
Peppermint also recently sig ..read more
Small Caps
1w ago
Akora Resources (ASX: AKO) managing director Paul Bibby joins Small Caps to discuss the robust results obtained in a new low start-up cost examination of its proposed Bekisopa DSO iron ore project in Madagascar.
The new scoping study has confirmed the project to be economically viable was an initial 2 million tonnes per annum direct shipping ore (DSO) operation.
The results also highlighted the viability of a low capital expenditure (CAPEX) option based on an initial open pit mining operation utilising the project’s DSO JORC indicated resource of 4.4 million tonnes.
While the scoping study res ..read more
Small Caps
2w ago
Elevate Uranium (ASX: EL8) managing director and chief executive officer Murray Hill joins Small Caps to discuss the company's success in significantly increasing the mineral resource estimate (MRE) for its Koppies uranium development in Namibia.
The recently released MRE update included a dramatic 136% increase in the Koppies resources to 48 million pounds and a 42% jump in Elevate's total Namibian numbers.
The company is not resting on its laurels and is aggressively looking to add to those impressive figures with an ongoing exploration campaign.
Elevate currently has three drill rigs in the ..read more
Small Caps
1M ago
Investigator Resources (ASX: IVR) managing director Andrew McIlwain joins Small Caps to discuss the significant progress the company is making at its Paris silver project in South Australia.
The company has recently successfully progressed and completed a number of key studies as it continues to advance its proposed development of Paris - Australia's highest-grade silver project.
Investigator is currently focused on a pre-feasibility study at Paris, with a number of key activities well advanced.
The company has recently contracted Melbourne-based engineering, procurement and construction consu ..read more
Small Caps
1M ago
Blue Energy (ASX: BLU) managing director John Phillips joins Small Caps to discuss the company's gas developments in Queensland.
The company recently revealed a 36% increase in the estimated total proved and probable (2P) reserves in its Sapphire Block gas development.
The new independent assessment of the Sapphire project also provided a 16% increase in 3P+2C aggregate gas resource available to 543 pj of recoverable gas.
The reserves and resources upgrade support the gas supply volume required under a non-binding MoU between Blue Energy and Queensland Pacific Metals.
In June, Blue Energy sign ..read more
Small Caps
1M ago
Chimeric Therapeutics (ASX: CHM) managing director and chief executive office Jennifer Chow joins Small Caps to discuss the successful results of a new brain cancer (glioblastoma) treatment trial.
The phase 1A trial achieved a 55% disease control rate (DCR) in patients treated with its CLTX CAR T solution, well above historical disease control rates.
Under that trial two patients exceeded a survival period of 14 months, while three patients remained alive and in follow up.
This is in direct comparison to survival expectations of around 7 months for patients after first line therapy.
Data obtai ..read more